Stevanato Group S.p.A. (STVN)
NYSE: STVN · IEX Real-Time Price · USD
28.40
-0.46 (-1.59%)
At close: Apr 18, 2024, 4:00 PM
28.77
+0.37 (1.30%)
After-hours: Apr 18, 2024, 7:16 PM EDT

Company Description

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.

The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A.

is a subsidiary of Stevanato Holding S.R.L.

Stevanato Group S.p.A.
Stevanato Group logo
Country Italy
Founded 1949
IPO Date Jul 16, 2021
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 5,634
CEO Franco Moro

Contact Details

Address:
Piombino Dese (Pd) Via Molinella, 17
Padua, L6 35017
Italy
Phone 39 049 9318173
Website stevanatogroup.com

Stock Details

Ticker Symbol STVN
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
IPO Price $21.00
CIK Code 0001849853
CUSIP Number T9224W109
ISIN Number IT0005452658
SIC Code 3841

Key Executives

Name Position
Franco Stevanato Executive Chairman
Franco Moro Chief Executive Officer and Director
Marco Dal Lago Chief Financial Officer
Ugo Gay Chief Operations Officer
Lorenzo Bendinelli Chief Information Officer
Lisa Miles Senior Vice President of Investor Relations
Paolo De Fabritiis Chief Human Resources Officer
Mauro Stocchi Chief Business Officer
Riccardo Butta President of Americas

Latest SEC Filings

Date Type Title
Mar 27, 2024 6-K Report of foreign issuer
Mar 26, 2024 6-K Report of foreign issuer
Mar 25, 2024 6-K Report of foreign issuer
Mar 25, 2024 424B5 Filing
Mar 21, 2024 6-K Report of foreign issuer
Mar 20, 2024 424B5 Filing
Mar 20, 2024 F-3ASR Filing
Mar 15, 2024 6-K Report of foreign issuer
Mar 7, 2024 20-F Annual and transition report of foreign private issuers
Mar 7, 2024 6-K Report of foreign issuer